BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

973 related articles for article (PubMed ID: 3257371)

  • 21. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.
    Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F
    Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA typing of maternal HLA in congenital complete heart block: comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Colombo G; Brucato A; Coluccio E; Compasso S; Luzzana C; Franceschini F; Quinzanini M; Scorza R
    Arthritis Rheum; 1999 Aug; 42(8):1757-64. PubMed ID: 10446878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Ro(SS-A) antibody positive Sjögren's/lupus erythematosus overlap syndrome.
    Provost TT; Watson R; Simmons-O'Brien E
    Lupus; 1997; 6(2):105-11. PubMed ID: 9061658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Ro/SSA and La/SSB antibodies.
    Franceschini F; Cavazzana I
    Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical constellation of annular erythema associated with anti-Ro/La autoantibodies.
    Lee CW
    J Korean Med Sci; 2000 Apr; 15(2):199-202. PubMed ID: 10803698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sjögren's syndrome in systemic lupus erythematosus.
    Andonopoulos AP; Skopouli FN; Dimou GS; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 Feb; 17(2):201-4. PubMed ID: 2319519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome.
    Hansen B; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():93-7. PubMed ID: 3495875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular definition of the Ro(SSA) particle(s): a frequent target of autoimmunity in systemic lupus erythematosus and Sjögren's syndrome.
    Reichlin M
    Br J Rheumatol; 1991; 30 Suppl 1():58-62. PubMed ID: 1991243
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical course of silent thyroiditis in a patient with Sjögren's syndrome. Concomitant changes of antithyroid antibodies and antinuclear antibody.
    Mitani Y; Shigemasa C; Taniguchi S; Tanaka T; Yoshida A; Mashiba H
    Arch Intern Med; 1988 Sep; 148(9):1974-5. PubMed ID: 3261973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of anti-Ro(SS-A) by using immunoimprint. Comparison with double diffusion in agar. Apropos of a series of 63 primary Gougerot-Sjögren syndromes].
    Meyer O; Haim T; Bourgeois P; Palazzo E; Ribard P; Belmatoug N; Kahn MF
    Rev Rhum Mal Osteoartic; 1991 Mar; 58(3):149-55. PubMed ID: 1905419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neonatal antinuclear antibodies and the lupus syndrome].
    Pennec Y; Colin A; Youinou P; Alix D
    Arch Fr Pediatr; 1985; 42(7):517-9. PubMed ID: 3878694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of anti-Ro antibodies in 2 cases of Sjögren's disease with multisystem involvement].
    Jaccard Y; di Stefano R; Bréaud P; Delacrétaz F; Fontolliet C; Pécoud A
    Schweiz Med Wochenschr; 1989 Jan; 119(3):84-7. PubMed ID: 2785287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
    Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
    J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid arthritis: anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster.
    Boire G; Ménard HA; Gendron M; Lussier A; Myhal D
    J Rheumatol; 1993 Oct; 20(10):1654-60. PubMed ID: 8295174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subacute cutaneous lupus erythematosus-immunogenetic associations.
    Watson RM; Talwar P; Alexander E; Bias WB; Provost TT
    J Autoimmun; 1991 Feb; 4(1):73-85. PubMed ID: 2031665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.